185 related articles for article (PubMed ID: 15670046)
1. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor.
Guerrero JA; Lozano ML; Castillo J; Benavente-García O; Vicente V; Rivera J
J Thromb Haemost; 2005 Feb; 3(2):369-76. PubMed ID: 15670046
[TBL] [Abstract][Full Text] [Related]
2. Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets.
Muñoz Y; Garrido A; Valladares L
Thromb Res; 2009 Mar; 123(5):740-4. PubMed ID: 18786699
[TBL] [Abstract][Full Text] [Related]
3. Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway.
Navarro-Núñez L; Lozano ML; Palomo M; Martínez C; Vicente V; Castillo J; Benavente-García O; Diaz-Ricart M; Escolar G; Rivera J
J Agric Food Chem; 2008 May; 56(9):2970-6. PubMed ID: 18410117
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets.
Navarro-Núñez L; Rivera J; Guerrero JA; Martínez C; Vicente V; Lozano ML
Br J Pharmacol; 2009 Nov; 158(6):1548-56. PubMed ID: 19814731
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells.
Guerrero JA; Navarro-Nuñez L; Lozano ML; Martínez C; Vicente V; Gibbins JM; Rivera J
Br J Clin Pharmacol; 2007 Aug; 64(2):133-44. PubMed ID: 17425630
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of luteolin‑4'‑O‑β‑D‑glucopyranoside on P2Y12 and thromboxane A2 receptor‑mediated amplification of platelet activation in vitro.
Xu H; Lu H; Zhu X; Wang W; Zhang Z; Fu H; Ma S; Luo Y; Fu J
Int J Mol Med; 2018 Jul; 42(1):615-624. PubMed ID: 29693158
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade.
Jin YR; Han XH; Lee JJ; Lim Y; Kim TJ; Yoo HS; Hong JT; Lee CK; Yun YP
J Pharmacol Sci; 2007 Oct; 105(2):193-200. PubMed ID: 17951980
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships.
Navarro-Núñez L; Castillo J; Lozano ML; Martínez C; Benavente-García O; Vicente V; Rivera J
J Agric Food Chem; 2009 Feb; 57(4):1589-94. PubMed ID: 19182941
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2.
Armstrong PC; Truss NJ; Ali FY; Dhanji AA; Vojnovic I; Zain ZN; Bishop-Bailey D; Paul-Clark MJ; Tucker AT; Mitchell JA; Warner TD
J Thromb Haemost; 2008 Nov; 6(11):1933-43. PubMed ID: 18752570
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Johnson GJ; Dunlop PC; Leis LA; From AH
Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for antiplatelet effect of onion: AA release inhibition, thromboxane A(2)synthase inhibition and TXA(2)/PGH(2)receptor blockade.
Moon CH; Jung YS; Kim MH; Lee SH; Baik EJ; Park SW
Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):277-83. PubMed ID: 10883058
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation by some flavonoids.
Tzeng SH; Ko WC; Ko FN; Teng CM
Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142
[TBL] [Abstract][Full Text] [Related]
14. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y
Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y
Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825
[TBL] [Abstract][Full Text] [Related]
15. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
Roger S; Pawlowski M; Habib A; Jandrot-Perrus M; Rosa JP; Bryckaert M
FEBS Lett; 2004 Jan; 556(1-3):227-35. PubMed ID: 14706855
[TBL] [Abstract][Full Text] [Related]
16. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
17. New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators.
Dogné JM; de Leval X; Hanson J; Frederich M; Lambermont B; Ghuysen A; Casini A; Masereel B; Ruan KH; Pirotte B; Kolh P
Curr Med Chem; 2004 May; 11(10):1223-41. PubMed ID: 15134516
[TBL] [Abstract][Full Text] [Related]
18. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
19. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
[TBL] [Abstract][Full Text] [Related]
20. MC-002 exhibits positive effects against platelets aggregation and endothelial dysfunction through thromboxane A2 inhibition.
Fang W; Wei J; Han D; Chen X; He G; Wu Q; Chu S; Li Y
Thromb Res; 2014 Apr; 133(4):610-5. PubMed ID: 24525312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
